<Record>
<Term>Recombinant Adenovirus-Interferon SCH 721015</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Gene Transfer or Gene Delivery Agent</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Biological Agent/Gene Transfer or Gene Delivery Agent/Recombinant Adenovirus-Interferon SCH 721015</ClassificationPath>
<BroaderTerm>Recombinant Adenovirus-Interferon SCH 721015</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Biological Agent</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Gene Transfer or Gene Delivery Agent</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>Recombinant Adenovirus-Interferon SCH 721015</Synonym>
<Synonym>SCH 721015</Synonym>
<Synonym>rAd-IFN SCH 721015</Synonym>
<Description>A replication-deficient recombinant adenovirus encoding human interferon alpha-2b with potential antineoplastic activity. Upon intravesical administration, recombinant adenovirus-interferon SCH 721015 infects nearby tumor cells and expresses INF alpha-2b intracellularly which activates the transcription and translation of genes whose products mediate antiviral, antiproliferative, antitumor, and immune-modulating effects.</Description>
<Source>NCI Thesaurus</Source>
</Record>
